Cetuximab for the first-line treatment of metastatic colorectal cancer.

C. Meads*, J. Round, S. Tubeuf, D. Moore, M. Pennant, S. Bayliss

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    46 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Cetuximab for the first-line treatment of metastatic colorectal cancer.'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Social Sciences